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cardiotoxicity (87%), however the difference was not statistically
significant.
Conclusions: AC CMP can occur at lower cumulative doses.
Doxorubicin dose, time to development of AC CMP and grade of
cardiotoxicity did not affect the response to treatment. Large
prospective studies to explore the role of biomarkers and genetic
polymorphism in early detection and prevention of AC CMP
respectively need to be conducted.
Takotsubo cardiomyopathy (TCM) versus dilated
cardiomyopathy (DCM)
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P G Institute of Medicine, GSVM Medical College, Kanpur, India
Aims: To study the clinical profile of Takotsubo cardiomyopathy&
DCMP.
Methods: The study was conducted on 60 patients in Deptt of
Medicine G.S.V.M. Medical college, in between January 2012 to
September 2013.
Inclusion criteria were: Modified Mayo Criteria.
 Signs & Symptoms of Heart failure
 New ECG abnormalities( ST- segment elevation or T-wave
inversion or modest elevation in cardiac troponin)
 Left ventricular ejection fraction < 45%
 Absence of obstructive coronary disease
Echo done in all cases
Results: There is a significant difference in the sex distribution
between the two types of cardiomyopathies ( p¼0.02), DCMP being
more common in males (68%) while TCM more common in fe-
males (90%).
None of the cases of TCM presented with pedal edema & pan-
systolic murmur while 66% cases of DCMP had pedal edema & all
of them had pansystolic murmur ( p < 0.001)
There is a significant association between psychological stress&
TCM (p<0.001)
There is a significant association between Alcohol & DCMP.
All TCM cases had a very good prognosis & all cases improved
significantly within 3 months
Conclusion: DCMP is more common in males(68%) while TCM is
more common in females (90%).
None of the cases of TCM presented with pedal edema & pan-
systolic murmur while cases of DCMP had pedal edema & all of
them had pansystolic murmur.
There is a significant association between psychological stress&
TCM.
There is a significant association between Alcohol & DCMP.
All TCM cases had a very good prognosis & all cases improved
significantly within 3 months with proper management and care.
Incidence of Ischemia in end stage renal disease
patients with uremic cardiomyopathy in Eastern
India
Madhumanti Panja, Ayan Kar, Debabrata Roy, Soumitra Kumar,
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Background: Uremic cardiomyopathy is the most important
cause of death amongst end stage renal disease. The incidence
of Ischemic heart disease (IHD) in such patients is only 11%
worldwide. However, incidence of IHD is unknown in Eastern
Indian end stage renal disease patients with uremic
cardiomyopathy.
Methods: A total of 90 patients who underwent renal trans-
plantation at our institute were enrolled for the study. All un-
derwent Echocardiography as routine pre-transplant evaluation
protocol. Those with uremic cardiomyopathy underwent Dobut-
amine Stress Echocardiography (DSE) for assessment of the
presence of IHD. All such patients were also evaluated for pres-
ence or absence of standard CAD risk factors.
Results: 30 out of 90 patients (33%) were diagnosed to have Uremic
cardiomyopathy. 23 patients were male and 7 were female. 11%
were smokers, 10% hypertensives, 9% diabetics and 10% were
dyslipidemic. DSE was positive in only 5 patients (16.66%).
Conclusion: The incidence of IHD in end stage renal failure pa-
tients with Uremic Cardiomyopathy in Eastern India is higher
than the world literature.
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Background: Angiotensin converting enzyme inhibitors (ACE-I) or
angiotensin receptor blockers (ARB) and beta blockers (BB) are
class I indications in heart failure (HF) patients with an ejection
fraction (EF) <40%. Little is known about the use of these medi-
cations in outpatients with systolic HF in India.
Methods: PINNACLE® India is the first cardiovascular quality
improvement program in India to capture, report and improve
outpatient performance measure. Among patients with EF <40%
enrolled between January 2012 and June 2014from 11 outpatient
centers, we evaluated the use of ACE-I/ARB, BB or both on any
outpatient encounter.
Results: In 52880 patients with reported EF, 15940 (30%) had an EF
40%.The frequency of ACE-I/ARB; BB; and combined ACE-I/
ARB+BB use was documented in 5257 (33%); 5450 (34%); and 4647
(29%) of patients with EF40%, respectively. Women, patients >65
years and those receiving care in practices without electronic
medical records had lower documented medication use(Ta-
ble).The number of patients receiving recommended medications
increased after the first 3 months of reporting and subsequently
remained steady(data not shown).
Conclusions: Among patients with systolic HF enrolled in the
PINNACLE® India Registry, about 2/3rddid not have documen-
tation of receipt of guideline recommended medications. A
small improvement was observed in follow-up reporting. These
results indicate an opportunity to improve quality of care
concordant with treatment guidelines for patients with EF <40%
in India.
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A decade with heart transplantation e Single
centre experience
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Background: Heart transplantation is being done at Frontier Life-
line Hospital & DR. K.M. Cherian Heart Foundation, Chennai since
2004. So far 41 heart transplants have taken place till date.
Methods and Results: A vast majority 80% of the transplant re-
cipients were male. A majority i.e 46% of the transplant recipients
were in the age group of 41 e 60 yrs and 36% of the transplant
recipients are in the age group of 21 e 40 yrs and 17% were in the
age group 0 -20 yrs old.
The major cause for cardiac transplantation is Dilated Cardio-
myopathy in 65% of the patients, Ischemic Cardiomyopathy in
17% and the rest were diagnosed as Restrictive Cardiomyopathy,
Hypertrophic Cardiomyopathy and Cardiac Tumor.
A vast majority 85% of the transplant recipient hearts were
taken from the hospitals in Chennai through ambulance (road)
and the remaining 15% of the hearts were taken from outside
Chennai through flight& ambulance (Vellore, Madurai, Bangalore,
Coimbatore).
Majority of the transplant surgeries were done by Bicaval tech-
nique. Immunosuppressant protocol started with induction in 50%
of patients. Immunosuppressants used were cyclosporine 70%,
tacrolimus 30%, mycophenolate 100% and prednisolone 100%.
No endomyocardial biopsy was done, evaluation of rejection is
done by ECHO criteria only. The causes of death among post
transplant patients were mostly infections, especially fungal in
90%, late rejection occurred 50% of transplant patients, early renal
failure in 70%, Anemia in 10%, complete heart block in 1% and
infection of urinary tract in 10% of patients.
Conclusion: Heart transplantation is here to stay. After changes in
our strategies of induction therapy and modification of immu-
nosuppression, our survival rates have improved.
ECG changes after heart transplantation e Single
center experience of a decade
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Background: Frontier Lifeline Hospital & DR. K.M. Cherian Heart
Foundation, Chennai has done maximum number of Heart
Transplants in India to our knowledge. The study reviews the
static and dynamic ECG changes seen in 41 heart transplantation
patients done in our center.
Methods & Results: ECG changes post transplantation can be
divided into two groups.
Fixed ECG changes which persists with the patients all through
his life. These fixed ECG changes appeared first time after heart
transplantation. These changes were right bundle branch block in
26% of patients, left bundle branch block in 10.52% & Sinus
tachycardia 5.26%, right axis deviation in 10.52%, left axis devia-
tion in 5.26%, poor R wave progression in 18.4%, Prolonged PR
interval 5.26%.
Dynamic ECG changes occurring anytime during post heart
transplantation which were of benign prognosis. There were
VPC’s especially VPC’s with LBBB morphology. LAE occurred
usually after 1 year of heart transplantation in 18% patients.
ECG changes major prognostic implication were junctional
tachycardia 2%, prolonged PR interval 8%, prolonged QTC interval
4%, decreased in QRS amplitude of ECG’s which portended a bad
prognosis 20%. Subsequent in size of QRS amplitude meant a
better prognosis. This is perhaps the largest number presented to
our knowledge with Indian patients.
Diagnostic issues in DCM: A proposal for universal
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Background: Dilated cardiomyopathy (DCM) is a common clinical
cardiology problem. Still, there is no uniform definition for this
entity. One popular definition for DCM is based on following pa-
rameters (1)LVEF  45% (2) fractional shortening  25% and (3)
LVEDD  112 % predicted value corrected for age and body surface
area. By tradition we use EDD to define LV dilatation but hemo-
dynamic principles would suggest LV ESD may be ideal to define
DCM as it is less dependent on preload. Further if MR is associated
it can confound LVEDD.
Methods: In this context, we analysed the relationship between
LV ESD, EDD, EF% and the impact of treatment on these parame-
ters. 25 patients with DCM who were attending our OPD were the
subjects of the study.
Table. Documentation of HF medications use from any outpatient encounter in patients with EF ≤40% by various
subgroups.
Medications
(any use)
Men
[N¼ 1225]
Women
[N¼ 3679]
<65 years
[N¼ 11874]
65 years
[N¼ 3949]
Receiving care in
a practice with
EMR [N¼15726]
Receiving care in
practice without
EMR [N¼214]
History of MI
[N¼ 2758]
No history of
MI [N¼ 13182]
ACE-I or ARB
n, (%)
4232(34.5) 1025(27.9) 3804(32.0) 1418(35.9) 5197(33.1) 60 (28.0) 1408(51.1) 3849 (29.2)
Beta blockers
n, (%)
4381(35.7) 1069(29.1) 3949(33.3) 1486(37.6) 5407(34.4) 43 (20.1) 1454(52.7) 3996 (30.3)
ACE-I/ARB and
beta blocker
n, (%)
3768(30.7) 879(23.9) 3366(28.4) 1273 (32.2) 4630(29.4) 17 (7.9) 1342 (48.7) 3305 (25.1)
ACE-I: angiotensin converting enzyme inhibitor, ARB: angiotensin receptor blocker, EF: ejection fraction, EMR: electronic medical record, HF:
heart failure, MI: myocardial infarction
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